Evidence map›Paper›PMID 17293063›Full record

ArticleToxicology letters2007

Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions.

Muhammad G Kibriya, Farzana Jasmine, Maria Argos, Wendy J Verret, Muhammad Rakibuz-Zaman, Alauddin Ahmed, Faruque Parvez, Habibul Ahsan

Abstract read
In one paragraph

Article in Toxicology letters, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Baseline comorbidities in a skin cancer prevention trial in Bangladesh.European journal of clinical investigation · 2013
    Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Nutrigenetics, nutrigenomics, and selenium.Frontiers in genetics · 2011
    Article
  14. Article
  15. Article
  16. Environmental arsenic exposure, selenium and sputum alpha-1 antitrypsin.Journal of exposure science & environmental epidemiology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Muhammad G KibriyaDepartment of Epidemiology, Mailman School of Public Health, Columbia University, USA. kibriya@uchicago.edu
Farzana Jasmine
Maria Argos
Wendy J Verret
Muhammad Rakibuz-Zaman
Alauddin Ahmed
Faruque Parvez
Habibul Ahsan

Funding

Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
Chemoprevention of arsenic-induced skin cancerR01CA107431 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2005 to 2014
$17.3M
Genetic Susceptibility to Arsenic-induced Skin CancerR01CA102484 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2004 to 2008
$2.0M
NCI NIH HHS R01 CA102484NCI NIH HHS R01 CA107431NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P30 ES09089NIEHS NIH HHS P42 ES010349NIEHS NIH HHS P42 ES10349
6 · The paper itself

Abstract

The molecular basis and downstream targets of oral selenium supplementation in individuals with elevated risk of cancer due to chronic exposure from environmental carcinogens has been largely unexplored. In this study, we investigated genome-wide differential gene expression in peripheral blood mononuclear cells (PBMC) from individuals with pre-malignant arsenic (As)-induced skin lesions before and after 6 months daily oral supplementation of 200 microg L-selenomethionine. The Affymetrix GeneChip Human 133A 2.0 array, containing probes for 22,277 gene transcripts, was used to assess gene expression. Three different normalization methods, RMA (robust multi-chip analysis), GC-RMA and PLIER (Probe logarithmic intensity error), were applied to explore differentially expressed genes. We identified a list of 28 biologically meaningful, significantly differentially expressed genes. Genes up-regulated by selenium supplementation included TNF, IL1B, IL8, SOD2, CXCL2 and several other immunological and oxidative stress-related genes. When mapped to a biological association network, many of the differentially expressed genes were found to regulate functional classes such as fibroblast growth factor, collagenase, matrix metalloproteinase and stromelysin-1, and thus, considered to affect cellular processes like apoptosis, proliferation and others. Many of the significantly up-regulated genes following selenium-supplementation were previously found by us to be down-regulated in a different set of individuals with As-induced skin lesions compared to those without. In conclusion, findings from this study may elucidate the biological effect of selenium supplementation in humans. Additionally, this study suggests that long-term selenium supplementation may revert some of the gene expression changes presumably induced by chronic As exposure in individuals with pre-malignant skin lesions.

Indexed as

AntioxidantsArsenicArsenic PoisoningBangladeshGene Expression ProfilingGene Expression Regulation, NeoplasticHumansLeukocytes, MononuclearMaleMiddle AgedOligonucleotide Array Sequence AnalysisPrecancerous ConditionsRNASelenomethionineSkin NeoplasmsWater Pollutants, ChemicalAntioxidantsArsenicRNASelenomethionineWater Pollutants, Chemical

Identifiers

PMID17293063
PMCPMC1924917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.